Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
about
Future of coagulation factor replacement therapyRecombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF.Novel drugs to treat hemophilia.Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients.The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia.Proteases as therapeutics.Advances in the treatment of inherited coagulation disorders.Investigational drugs for coagulation disorders.Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo.Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached His6-protein.Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).
P2860
Q26820824-292C8087-3328-407D-B856-EE4EE84D900CQ34548522-69ADE7D2-A5B5-44B4-B161-D3D7108EA8DAQ35167279-5CAAE728-104F-4656-965F-DD202C0D6240Q37679949-C9929A6D-B119-4D9D-8D43-C3A80F8AC152Q37775029-55467A91-FDA3-4D71-ADED-F5BFA3771A17Q37778292-677ABF26-C60F-43BD-8DFB-89E995FE0F85Q37790614-5B638C91-A902-47F6-BF9F-5899997E02E4Q37853216-DCF93865-3F25-4C2E-B224-3E5EB2979BE0Q38100271-1202F972-5FC6-41F0-A45C-4331B90D48B7Q38106245-982CC7D2-D0D6-48A3-8D7D-B298278DD07BQ39591239-6A45E529-B24A-492B-A155-2D41DDB0445AQ40672864-17BCFEB2-784C-4976-B74A-D5C58E9AA268Q45869314-ED651212-EC5C-43E7-9745-8FA03E0EA0B8
P2860
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
@en
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
@nl
type
label
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
@en
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
@nl
prefLabel
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
@en
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
@nl
P2093
P2860
P1433
P1476
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
@en
P2093
L Carmel-Goren
M Goldenberg-Furmanov
M Robinson
P2860
P304
P356
10.1111/J.1365-2516.2008.01741.X
P577
2008-04-03T00:00:00Z